ProPublica investigates a moving story of injustice and the dangers of flawed judgments by expert witnesses. And the Seattle Times reports on the Twisted Ethics of an Expert Witness.
Tuesday, June 28, 2011
A moving story of injustice and the dangers of flawed judgments by expert witnesses
Posted by
Willow
at
2:24 pm
Labels: Expert Witnesses, injustice, ProPublica
Monday, May 23, 2011
More about Drug Industry Ties to Medical Societies
ProPublica reports further about Drug Industry Ties to Medical Societies. "As we reported earlier this month, financial links between these professional societies and the drug and device industries are a widespread concern. The Heart Rhythm Society got nearly half of its $16 million in donations last year from companies that make drugs and devices used to control abnormal heart rhythms. The Society for Cardiac Angiography and Interventions took in $4.7 million, more than half of its total receipts in 2009, from drug and device manufacturers." In the words of the old proverb, "He who pays the piper, calls the tune," and in today's words, "Follow the money!"
Posted by
Willow
at
3:32 pm
Labels: corruption, drug and device manufacturers, Heart Rhythm Society, ProPublica, Society for Cardiac Angiography and Interventions
Sunday, May 15, 2011
ProPublica is investigating how drug company money reaches physicians
ProPublica is investigating how Pharmaceuticals Industry money reaches physicians, and the credentials and calibre of the physicians it uses. See this article.
Extract: "In 2001, the U.S. Food and Drug Administration ordered Pennsylvania doctor James I. McMillen to stop “false or misleading” promotions of the painkiller Celebrex, saying he minimized risks and touted it for unapproved uses. Still, three other leading drug makers paid the rheumatologist $224,163 over 18 months to deliver talks to other physicians about their drugs."
There are many interesting Comments beneath the article.
Posted by
Willow
at
2:22 pm
Labels: bribery, corporate corruption of science, drug makers, Pharmaceutical companies, ProPublica

